Clinical Trials Browser

Terminated × OTHER × Octreotide × Clear all

NCT04027348 2022-11-29

Palliative Management of Inoperable Malignant Bowel Obstruction

Phase 2 Terminated

15 enrolled 10 charts

Intestinal Obstruction

NCT03791736 2022-07-28

SANDOSTATINE

Phase NA Terminated

Breast Neoplasms, Lymphocele

NCT02032784 2020-07-16

Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding

Phase 4 Terminated

Adenoma

NCT04140409 2019-10-25

SCIROCCO

Phase 4 Terminated

Neuroendocrine Tumors, Serotonin Syndrome

NCT01469338 2014-11-24

Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel

Phase 2 Terminated

Diarrhea, Prostatic Neoplasms

NCT00510224 2013-12-11

Sandostatin for Patients With Androgen Independent Prostate Cancer

Phase 2 Terminated

13 enrolled 4 charts

Prostatic Neoplasms

NCT00466856 2012-05-18

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Phase 2 Terminated

EndocrineHead & Neck

Vipoma, Glucagonoma, Head and Neck Neoplasms, Insulinoma, Adenoma, Islet Cell, Neoplasm Metastasis, Neoplasms, Pheochromocytoma, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary